
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Document</i></p>
<p style="font-size: small; color: grey;"><i>Page 93 of 114</i></p>
<p style="font-size: small; color: grey;"><i>Aerie_10k_093.pdf</i></p>
<p>AERIE PHARMACEUTICALS, INC. Consolidated Balance Sheets (in thousands, except share and per share data)</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="2">DECEMBER 31,</th>
	</tr>
	<tr>
		<th>2017</th>
		<th>2016</th>
	</tr>
	<tr>
		<td>Assets</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Current assets</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Cash and cash equivalents</td>
		<td>$ 197,569</td>
		<td>$ 197,945</td>
	</tr>
	<tr>
		<td>Short-term investments</td>
		<td>52,086</td>
		<td>35,717</td>
	</tr>
	<tr>
		<td>Prepaid expenses and other current assets</td>
		<td>4,487</td>
		<td>4,028</td>
	</tr>
	<tr>
		<td>Total current assets</td>
		<td>254,142</td>
		<td>237,690</td>
	</tr>
	<tr>
		<td>Property, plant and equipment, net</td>
		<td>31,932</td>
		<td>7,857</td>
	</tr>
	<tr>
		<td>Other assets</td>
		<td>4,202</td>
		<td>2,707</td>
	</tr>
	<tr>
		<td>Total assets</td>
		<td>$ 290,276</td>
		<td>$ 248,254</td>
	</tr>
	<tr>
		<td>Liabilities and Stockholders&#x27; Equity</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Current liabilities</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Accounts payable</td>
		<td>$ 6,245</td>
		<td>$ 5,610</td>
	</tr>
	<tr>
		<td>Accrued expenses and other current liabilities</td>
		<td>18,939</td>
		<td>13,761</td>
	</tr>
	<tr>
		<td>Total current liabilities</td>
		<td>25,184</td>
		<td>19,371</td>
	</tr>
	<tr>
		<td>Convertible notes, net</td>
		<td>123,845</td>
		<td>123,539</td>
	</tr>
	<tr>
		<td>Other non-current liabilities</td>
		<td>5,648</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Total liabilities</td>
		<td>154,677</td>
		<td>142,910</td>
	</tr>
	<tr>
		<td>Commitments and contingencies (Note 11)</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Stockholders&#x27; equity</td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Preferred stock, $0.001 par value; 15,000,000 shares authorized as of December 31, 2017 and December 31, 2016; None issued and outstanding</td>
		<td>—</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Common stock, $0.001 par value; 150,000,000 shares authorized as of December 31, 2017 and December 31, 2016; 36,947,637 and 33,458,607 shares issued and outstanding as of December 31, 2017 and December 31, 2016, respectively</td>
		<td>37</td>
		<td>33</td>
	</tr>
	<tr>
		<td>Additional paid-in capital</td>
		<td>597,318</td>
		<td>422,002</td>
	</tr>
	<tr>
		<td>Accumulated other comprehensive loss</td>
		<td>(28)</td>
		<td>(68)</td>
	</tr>
	<tr>
		<td>Accumulated deficit</td>
		<td>(461,728)</td>
		<td>(316,623)</td>
	</tr>
	<tr>
		<td>Total stockholders&#x27; equity</td>
		<td>135,599</td>
		<td>105,344</td>
	</tr>
	<tr>
		<td>Total liabilities and stockholders&#x27; equity</td>
		<td>$ 290,276</td>
		<td>$ 248,254</td>
	</tr>
</table>
<p>The accompanying notes are an integral part of these consolidated financial statements.</p>
<p style="font-size: small; color: grey;"><i>F-4</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>

</body>
</html>
